Related Experiment Video
Updated: Aug 9, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Islet Autoantibody Patterns Vary by Race and Ethnicity and Area Deprivation Index for Individuals at Risk for Type 1
Ananta Addala1, Susanne Cabrera2, David Cuthbertson3
1Stanford University, Stanford, CA.
Objective:
Islet autoantibody positivity (AB+) has not been evaluated across different race, ethnicity, and socioeconomic deprivation categories in individuals at risk for type 1 diabetes. We examined data from TrialNet of persons screened for ABs and evaluated patterns by race and ethnicity and socioeconomic deprivation.
Research Design And Methods:
This analysis included 139,963 relatives of people with type 1 diabetes screened by TrialNet between 9 January 2012 and 31 December 2022. Race and ethnicity were categorized as non-Hispanic White, Hispanic, non-Hispanic Black, and non-Hispanic other. Home addresses were used to assign deprivation, ranging from least deprived (1) to most deprived (100), analyzed in quintiles. Descriptive and multivariate analyses assessed associations among race and ethnicity, deprivation, and AB+, adjusting for age and protocol period.
Results:
Single AB+ (SAB+) and multiple AB+ (MAB+) varied by age, race and ethnicity, and deprivation. Younger individuals had increased odds of MAB+ and decreased odds of SAB+. Non-Hispanic Black participants had significantly higher odds of AB+ (adjusted odds ratio 1.44 [95% CI 1.29, 1.62]), SAB+ (1.59 [1.38, 1.85]), and MAB+ (1.26 [1.06, 1.51]), while Hispanic individuals had higher odds of SAB+ (1.26 [1.15, 1.39]) and lower odds of MAB+ (0.81 [0.72, 0.91]) compared with non-Hispanic White individuals. Lowest deprivation was associated with higher odds of MAB+ (1.21 [1.06, 1.37]) but not SAB+.
Conclusions:
AB+ patterns vary by race, ethnicity, and deprivation. Screening and prevention strategies should be designed to identify individuals at risk based on these factors to enable equitable risk stratification and access to diabetes preventive therapies.
More Related Videos
Related Concept Videos
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations

